The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be ...
COMBRIAX is the world's first flu plus COVID combination vaccine to receive a positive CHMP opinion recommending ...
In issuing a positive recommendation, the EMA has diverged from the FDA, which has set higher approval standards for ...
Moderna said it met with the FDA on Tuesday to discuss the vaccine and afterward, the U.S. regulator accepted a revised ...
Straight Arrow News (English) on MSN
FDA to review Moderna's mRNA flu vaccine after initial rejection
Moderna announced that the FDA will review its new mRNA flu vaccine, a reversal less than two weeks after the agency refused ...
The FDA agreed to review Moderna’s experimental mRNA influenza vaccine after Moderna resubmitted its application with modifications.
Signed Memorandum of Understanding supports "Plan Mexico," Mexico's strategic initiative to build a local mRNA ...
Feb 27 (Reuters) - Europe's medicines regulator on Friday recommended approval for Moderna's mCombriax, paving the way for it to become the first combined shot for protecting people aged 50 and older ...
With the reversal from the FDA, Moderna said it is aiming to make the vaccine available for the 2026-27 flu season.
The US Food and Drug Administration has reversed course and will review a new mRNA flu vaccine from Moderna, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results